APO Research
Talk to an analyst

APO RESEARCH · REPORT

Low Molecular Weight Heparin Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Low Molecular Weight Heparin Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025191 pages

Choose your research edition.

Industry ResearchLow Molecular Weight Heparin Injection Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Low Molecular Weight Heparin Injection Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Low Molecular Weight Heparin Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Low Molecular Weight Heparin Injection Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Low Molecular Weight Heparin Injection Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Low Molecular Weight Heparin Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Low Molecular Weight Heparin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Low Molecular Weight Heparin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Low Molecular Weight Heparin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Low Molecular Weight Heparin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Low Molecular Weight Heparin Injection include Tianjin Chasesun Pharmaceutical, Qilu Pharmaceutical, Kunming Jida Pharmaceutical, Jiangsu Wanbang Biopharmaceuticals, Hebei Changshan Biochemical Pharmaceutical, Hainan GT-Unipul Pharmaceutical, He'nan Xuchang Huaren Pharmaceutical, Sanofi and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Low Molecular Weight Heparin Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Low Molecular Weight Heparin Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Low Molecular Weight Heparin Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Low Molecular Weight Heparin Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Low Molecular Weight Heparin Injection Segment by Company

Tianjin Chasesun Pharmaceutical

Qilu Pharmaceutical

Kunming Jida Pharmaceutical

Jiangsu Wanbang Biopharmaceuticals

Hebei Changshan Biochemical Pharmaceutical

Hainan GT-Unipul Pharmaceutical

He'nan Xuchang Huaren Pharmaceutical

Sanofi

Pfizer

Opocrin

Aspen

Low Molecular Weight Heparin Injection Segment by Type

Low Molecular Weight Heparin Sodium Injection

Low Molecular Weight Heparin Calcium Injection

Low Molecular Weight Heparin Injection Segment by Application

Treatment of Venous Thromboembolism

Complications of Pregnancy

Cardioversion of Atrial Fibrillation/Flutter

Others

Low Molecular Weight Heparin Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Low Molecular Weight Heparin Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Low Molecular Weight Heparin Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Low Molecular Weight Heparin Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Low Molecular Weight Heparin Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Low Molecular Weight Heparin Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Low Molecular Weight Heparin Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Low Molecular Weight Heparin Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Low Molecular Weight Heparin Injection Industry Trends Table 2. Low Molecular Weight Heparin Injection Industry Drivers Table 3. Low Molecular Weight Heparin Injection Industry Opportunities and Challenges Table 4. Low Molecular Weight Heparin Injection Industry Restraints Table 5. Global Low Molecular Weight Heparin Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Low Molecular Weight Heparin Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Low Molecular Weight Heparin Injection Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Low Molecular Weight Heparin Injection Sales Market Share by Manufacturers Table 9. Global Low Molecular Weight Heparin Injection Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Low Molecular Weight Heparin Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Low Molecular Weight Heparin Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Low Molecular Weight Heparin Injection Manufacturers, Product Type & Application Table 13. Global Low Molecular Weight Heparin Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Low Molecular Weight Heparin Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Low Molecular Weight Heparin Sodium Injection Table 17. Major Manufacturers of Low Molecular Weight Heparin Calcium Injection Table 18. Global Low Molecular Weight Heparin Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Low Molecular Weight Heparin Injection Sales by Type (2021-2026) & (K Units) Table 20. Global Low Molecular Weight Heparin Injection Sales by Type (2027-2032) & (K Units) Table 21. Global Low Molecular Weight Heparin Injection Sales Market Share by Type (2021-2026) Table 22. Global Low Molecular Weight Heparin Injection Sales Market Share by Type (2027-2032) Table 23. Global Low Molecular Weight Heparin Injection Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Low Molecular Weight Heparin Injection Revenue by Type (2021-2026) & (K Units) Table 25. Global Low Molecular Weight Heparin Injection Revenue by Type (2027-2032) & (K Units) Table 26. Global Low Molecular Weight Heparin Injection Revenue Market Share by Type (2021-2026) Table 27. Global Low Molecular Weight Heparin Injection Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Treatment of Venous Thromboembolism Table 29. Major Manufacturers of Complications of Pregnancy Table 30. Major Manufacturers of Cardioversion of Atrial Fibrillation/Flutter Table 31. Major Manufacturers of Others Table 32. Global Low Molecular Weight Heparin Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Low Molecular Weight Heparin Injection Sales by Application (2021-2026) & (K Units) Table 34. Global Low Molecular Weight Heparin Injection Sales by Application (2027-2032) & (K Units) Table 35. Global Low Molecular Weight Heparin Injection Sales Market Share by Application (2021-2026) Table 36. Global Low Molecular Weight Heparin Injection Sales Market Share by Application (2027-2032) Table 37. Global Low Molecular Weight Heparin Injection Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Low Molecular Weight Heparin Injection Revenue by Application (2021-2026) & (K Units) Table 39. Global Low Molecular Weight Heparin Injection Revenue by Application (2027-2032) & (K Units) Table 40. Global Low Molecular Weight Heparin Injection Revenue Market Share by Application (2021-2026) Table 41. Global Low Molecular Weight Heparin Injection Revenue Market Share by Application (2027-2032) Table 42. Global Low Molecular Weight Heparin Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Low Molecular Weight Heparin Injection Sales by Region (2021-2026) & (K Units) Table 44. Global Low Molecular Weight Heparin Injection Sales Market Share by Region (2021-2026) Table 45. Global Low Molecular Weight Heparin Injection Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Low Molecular Weight Heparin Injection Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Low Molecular Weight Heparin Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Low Molecular Weight Heparin Injection Sales by Country (2021-2026) & (K Units) Table 49. North America Low Molecular Weight Heparin Injection Sales by Country (2027-2032) & (K Units) Table 50. Europe Low Molecular Weight Heparin Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Low Molecular Weight Heparin Injection Sales by Country (2021-2026) & (K Units) Table 52. Europe Low Molecular Weight Heparin Injection Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Low Molecular Weight Heparin Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Low Molecular Weight Heparin Injection Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Low Molecular Weight Heparin Injection Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Low Molecular Weight Heparin Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Low Molecular Weight Heparin Injection Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Low Molecular Weight Heparin Injection Sales by Country (2027-2032) & (K Units) Table 59. Global Low Molecular Weight Heparin Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Low Molecular Weight Heparin Injection Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Low Molecular Weight Heparin Injection Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Low Molecular Weight Heparin Injection Revenue Market Share by Region (2021-2026) Table 63. Global Low Molecular Weight Heparin Injection Revenue Market Share by Region (2027-2032) Table 64. Tianjin Chasesun Pharmaceutical Company Information Table 65. Tianjin Chasesun Pharmaceutical Business Overview Table 66. Tianjin Chasesun Pharmaceutical Low Molecular Weight Heparin Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Tianjin Chasesun Pharmaceutical Low Molecular Weight Heparin Injection Product Portfolio Table 68. Tianjin Chasesun Pharmaceutical Recent Development Table 69. Qilu Pharmaceutical Company Information Table 70. Qilu Pharmaceutical Business Overview Table 71. Qilu Pharmaceutical Low Molecular Weight Heparin Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Qilu Pharmaceutical Low Molecular Weight Heparin Injection Product Portfolio Table 73. Qilu Pharmaceutical Recent Development Table 74. Kunming Jida Pharmaceutical Company Information Table 75. Kunming Jida Pharmaceutical Business Overview Table 76. Kunming Jida Pharmaceutical Low Molecular Weight Heparin Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Kunming Jida Pharmaceutical Low Molecular Weight Heparin Injection Product Portfolio Table 78. Kunming Jida Pharmaceutical Recent Development Table 79. Jiangsu Wanbang Biopharmaceuticals Company Information Table 80. Jiangsu Wanbang Biopharmaceuticals Business Overview Table 81. Jiangsu Wanbang Biopharmaceuticals Low Molecular Weight Heparin Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Jiangsu Wanbang Biopharmaceuticals Low Molecular Weight Heparin Injection Product Portfolio Table 83. Jiangsu Wanbang Biopharmaceuticals Recent Development Table 84. Hebei Changshan Biochemical Pharmaceutical Company Information Table 85. Hebei Changshan Biochemical Pharmaceutical Business Overview Table 86. Hebei Changshan Biochemical Pharmaceutical Low Molecular Weight Heparin Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Hebei Changshan Biochemical Pharmaceutical Low Molecular Weight Heparin Injection Product Portfolio Table 88. Hebei Changshan Biochemical Pharmaceutical Recent Development Table 89. Hainan GT-Unipul Pharmaceutical Company Information Table 90. Hainan GT-Unipul Pharmaceutical Business Overview Table 91. Hainan GT-Unipul Pharmaceutical Low Molecular Weight Heparin Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Hainan GT-Unipul Pharmaceutical Low Molecular Weight Heparin Injection Product Portfolio Table 93. Hainan GT-Unipul Pharmaceutical Recent Development Table 94. He'nan Xuchang Huaren Pharmaceutical Company Information Table 95. He'nan Xuchang Huaren Pharmaceutical Business Overview Table 96. He'nan Xuchang Huaren Pharmaceutical Low Molecular Weight Heparin Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. He'nan Xuchang Huaren Pharmaceutical Low Molecular Weight Heparin Injection Product Portfolio Table 98. He'nan Xuchang Huaren Pharmaceutical Recent Development Table 99. Sanofi Company Information Table 100. Sanofi Business Overview Table 101. Sanofi Low Molecular Weight Heparin Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Sanofi Low Molecular Weight Heparin Injection Product Portfolio Table 103. Sanofi Recent Development Table 104. Pfizer Company Information Table 105. Pfizer Business Overview Table 106. Pfizer Low Molecular Weight Heparin Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Pfizer Low Molecular Weight Heparin Injection Product Portfolio Table 108. Pfizer Recent Development Table 109. Opocrin Company Information Table 110. Opocrin Business Overview Table 111. Opocrin Low Molecular Weight Heparin Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Opocrin Low Molecular Weight Heparin Injection Product Portfolio Table 113. Opocrin Recent Development Table 114. Aspen Company Information Table 115. Aspen Business Overview Table 116. Aspen Low Molecular Weight Heparin Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Aspen Low Molecular Weight Heparin Injection Product Portfolio Table 118. Aspen Recent Development Table 119. Key Raw Materials Table 120. Raw Materials Key Suppliers Table 121. Low Molecular Weight Heparin Injection Distributors List Table 122. Low Molecular Weight Heparin Injection Customers List Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Low Molecular Weight Heparin Injection Product Image Figure 2. Global Low Molecular Weight Heparin Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Low Molecular Weight Heparin Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Low Molecular Weight Heparin Injection Sales (2021-2032) & (K Units) Figure 5. Global Low Molecular Weight Heparin Injection Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Low Molecular Weight Heparin Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Low Molecular Weight Heparin Sodium Injection Image Figure 9. Low Molecular Weight Heparin Calcium Injection Image Figure 10. Global Low Molecular Weight Heparin Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Low Molecular Weight Heparin Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Low Molecular Weight Heparin Injection Sales Market Share by Type (2021-2032) Figure 13. Global Low Molecular Weight Heparin Injection Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Low Molecular Weight Heparin Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Low Molecular Weight Heparin Injection Revenue Market Share by Type (2021-2032) Figure 16. Treatment of Venous Thromboembolism Image Figure 17. Complications of Pregnancy Image Figure 18. Cardioversion of Atrial Fibrillation/Flutter Image Figure 19. Others Image Figure 20. Global Low Molecular Weight Heparin Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Low Molecular Weight Heparin Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Low Molecular Weight Heparin Injection Sales Market Share by Application (2021-2032) Figure 23. Global Low Molecular Weight Heparin Injection Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Low Molecular Weight Heparin Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Low Molecular Weight Heparin Injection Revenue Market Share by Application (2021-2032) Figure 26. North America Low Molecular Weight Heparin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Low Molecular Weight Heparin Injection Sales Market Share by Country (2021-2032) Figure 28. U.S. Low Molecular Weight Heparin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Low Molecular Weight Heparin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Low Molecular Weight Heparin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Low Molecular Weight Heparin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Low Molecular Weight Heparin Injection Sales Market Share by Country (2021-2032) Figure 33. Germany Low Molecular Weight Heparin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Low Molecular Weight Heparin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Low Molecular Weight Heparin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Low Molecular Weight Heparin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Low Molecular Weight Heparin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Low Molecular Weight Heparin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Low Molecular Weight Heparin Injection Sales Market Share by Country (2021-2032) Figure 40. China Low Molecular Weight Heparin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Low Molecular Weight Heparin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Low Molecular Weight Heparin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Low Molecular Weight Heparin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Low Molecular Weight Heparin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Low Molecular Weight Heparin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Low Molecular Weight Heparin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Low Molecular Weight Heparin Injection Sales Market Share by Country (2021-2032) Figure 48. Brazil Low Molecular Weight Heparin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Low Molecular Weight Heparin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Low Molecular Weight Heparin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Low Molecular Weight Heparin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Low Molecular Weight Heparin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Low Molecular Weight Heparin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Low Molecular Weight Heparin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Low Molecular Weight Heparin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Low Molecular Weight Heparin Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Low Molecular Weight Heparin Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Low Molecular Weight Heparin Injection Revenue (2021-2032) & (US$ Million) Figure 59. North America Low Molecular Weight Heparin Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Low Molecular Weight Heparin Injection Revenue (2021-2032) & (US$ Million) Figure 61. Europe Low Molecular Weight Heparin Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Low Molecular Weight Heparin Injection Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Low Molecular Weight Heparin Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Low Molecular Weight Heparin Injection Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Low Molecular Weight Heparin Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Low Molecular Weight Heparin Injection Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Low Molecular Weight Heparin Injection Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Low Molecular Weight Heparin Sodium Injection
  • Low Molecular Weight Heparin Calcium Injection
Applications
  • Treatment of Venous Thromboembolism
  • Complications of Pregnancy
  • Cardioversion of Atrial Fibrillation/Flutter
  • Others
Companies covered
  • Tianjin Chasesun Pharmaceutical
  • Qilu Pharmaceutical
  • Kunming Jida Pharmaceutical
  • Jiangsu Wanbang Biopharmaceuticals
  • Hebei Changshan Biochemical Pharmaceutical
  • Hainan GT-Unipul Pharmaceutical
  • He'nan Xuchang Huaren Pharmaceutical
  • Sanofi
  • Pfizer
  • Opocrin
  • Aspen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Low Molecular Weight Heparin Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Low Molecular Weight Heparin Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Low Molecular Weight Heparin Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Low Molecular Weight Heparin Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Low Molecular Weight Heparin Injection Market Dynamics
  1. 2.1 Low Molecular Weight Heparin Injection Industry Trends
  2. 2.2 Low Molecular Weight Heparin Injection Industry Drivers
  3. 2.3 Low Molecular Weight Heparin Injection Industry Opportunities and Challenges
  4. 2.4 Low Molecular Weight Heparin Injection Industry Restraints
3 Low Molecular Weight Heparin Injection Market by Manufacturers
  1. 3.1 Global Low Molecular Weight Heparin Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Low Molecular Weight Heparin Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Low Molecular Weight Heparin Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Low Molecular Weight Heparin Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Low Molecular Weight Heparin Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Low Molecular Weight Heparin Injection Manufacturers, Product Type & Application
  7. 3.7 Global Low Molecular Weight Heparin Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Low Molecular Weight Heparin Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Low Molecular Weight Heparin Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Low Molecular Weight Heparin Injection Tier 1, Tier 2, and Tier 3
4 Low Molecular Weight Heparin Injection Market by Type
  1. 4.1 Low Molecular Weight Heparin Injection Type Introduction
  2. 4.1.1 Low Molecular Weight Heparin Sodium Injection
  3. 4.1.2 Low Molecular Weight Heparin Calcium Injection
  4. 4.2 Global Low Molecular Weight Heparin Injection Sales by Type
  5. 4.2.1 Global Low Molecular Weight Heparin Injection Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Low Molecular Weight Heparin Injection Sales by Type (2021-2032)
  7. 4.2.3 Global Low Molecular Weight Heparin Injection Sales Market Share by Type (2021-2032)
  8. 4.3 Global Low Molecular Weight Heparin Injection Revenue by Type
  9. 4.3.1 Global Low Molecular Weight Heparin Injection Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Low Molecular Weight Heparin Injection Revenue by Type (2021-2032)
  11. 4.3.3 Global Low Molecular Weight Heparin Injection Revenue Market Share by Type (2021-2032)
5 Low Molecular Weight Heparin Injection Market by Application
  1. 5.1 Low Molecular Weight Heparin Injection Application Introduction
  2. 5.1.1 Treatment of Venous Thromboembolism
  3. 5.1.2 Complications of Pregnancy
  4. 5.1.3 Cardioversion of Atrial Fibrillation/Flutter
  5. 5.1.4 Others
  6. 5.2 Global Low Molecular Weight Heparin Injection Sales by Application
  7. 5.2.1 Global Low Molecular Weight Heparin Injection Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Low Molecular Weight Heparin Injection Sales by Application (2021-2032)
  9. 5.2.3 Global Low Molecular Weight Heparin Injection Sales Market Share by Application (2021-2032)
  10. 5.3 Global Low Molecular Weight Heparin Injection Revenue by Application
  11. 5.3.1 Global Low Molecular Weight Heparin Injection Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Low Molecular Weight Heparin Injection Revenue by Application (2021-2032)
  13. 5.3.3 Global Low Molecular Weight Heparin Injection Revenue Market Share by Application (2021-2032)
6 Global Low Molecular Weight Heparin Injection Sales by Region
  1. 6.1 Global Low Molecular Weight Heparin Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Low Molecular Weight Heparin Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Low Molecular Weight Heparin Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Low Molecular Weight Heparin Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Low Molecular Weight Heparin Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Low Molecular Weight Heparin Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Low Molecular Weight Heparin Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Low Molecular Weight Heparin Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Low Molecular Weight Heparin Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Low Molecular Weight Heparin Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Low Molecular Weight Heparin Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Low Molecular Weight Heparin Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Low Molecular Weight Heparin Injection Revenue by Region
  1. 7.1 Global Low Molecular Weight Heparin Injection Revenue by Region
  2. 7.1.1 Global Low Molecular Weight Heparin Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Low Molecular Weight Heparin Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Low Molecular Weight Heparin Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Low Molecular Weight Heparin Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Low Molecular Weight Heparin Injection Revenue (2021-2032)
  8. 7.2.2 North America Low Molecular Weight Heparin Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Low Molecular Weight Heparin Injection Revenue (2021-2032)
  11. 7.3.2 Europe Low Molecular Weight Heparin Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Low Molecular Weight Heparin Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Low Molecular Weight Heparin Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Low Molecular Weight Heparin Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Low Molecular Weight Heparin Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Tianjin Chasesun Pharmaceutical
  2. 8.1.1 Tianjin Chasesun Pharmaceutical Company Information
  3. 8.1.2 Tianjin Chasesun Pharmaceutical Business Overview
  4. 8.1.3 Tianjin Chasesun Pharmaceutical Low Molecular Weight Heparin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Tianjin Chasesun Pharmaceutical Low Molecular Weight Heparin Injection Product Portfolio
  6. 8.1.5 Tianjin Chasesun Pharmaceutical Recent Developments
  7. 8.2 Qilu Pharmaceutical
  8. 8.2.1 Qilu Pharmaceutical Company Information
  9. 8.2.2 Qilu Pharmaceutical Business Overview
  10. 8.2.3 Qilu Pharmaceutical Low Molecular Weight Heparin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Qilu Pharmaceutical Low Molecular Weight Heparin Injection Product Portfolio
  12. 8.2.5 Qilu Pharmaceutical Recent Developments
  13. 8.3 Kunming Jida Pharmaceutical
  14. 8.3.1 Kunming Jida Pharmaceutical Company Information
  15. 8.3.2 Kunming Jida Pharmaceutical Business Overview
  16. 8.3.3 Kunming Jida Pharmaceutical Low Molecular Weight Heparin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Kunming Jida Pharmaceutical Low Molecular Weight Heparin Injection Product Portfolio
  18. 8.3.5 Kunming Jida Pharmaceutical Recent Developments
  19. 8.4 Jiangsu Wanbang Biopharmaceuticals
  20. 8.4.1 Jiangsu Wanbang Biopharmaceuticals Company Information
  21. 8.4.2 Jiangsu Wanbang Biopharmaceuticals Business Overview
  22. 8.4.3 Jiangsu Wanbang Biopharmaceuticals Low Molecular Weight Heparin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Jiangsu Wanbang Biopharmaceuticals Low Molecular Weight Heparin Injection Product Portfolio
  24. 8.4.5 Jiangsu Wanbang Biopharmaceuticals Recent Developments
  25. 8.5 Hebei Changshan Biochemical Pharmaceutical
  26. 8.5.1 Hebei Changshan Biochemical Pharmaceutical Company Information
  27. 8.5.2 Hebei Changshan Biochemical Pharmaceutical Business Overview
  28. 8.5.3 Hebei Changshan Biochemical Pharmaceutical Low Molecular Weight Heparin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Hebei Changshan Biochemical Pharmaceutical Low Molecular Weight Heparin Injection Product Portfolio
  30. 8.5.5 Hebei Changshan Biochemical Pharmaceutical Recent Developments
  31. 8.6 Hainan GT-Unipul Pharmaceutical
  32. 8.6.1 Hainan GT-Unipul Pharmaceutical Company Information
  33. 8.6.2 Hainan GT-Unipul Pharmaceutical Business Overview
  34. 8.6.3 Hainan GT-Unipul Pharmaceutical Low Molecular Weight Heparin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Hainan GT-Unipul Pharmaceutical Low Molecular Weight Heparin Injection Product Portfolio
  36. 8.6.5 Hainan GT-Unipul Pharmaceutical Recent Developments
  37. 8.7 He'nan Xuchang Huaren Pharmaceutical
  38. 8.7.1 He'nan Xuchang Huaren Pharmaceutical Company Information
  39. 8.7.2 He'nan Xuchang Huaren Pharmaceutical Business Overview
  40. 8.7.3 He'nan Xuchang Huaren Pharmaceutical Low Molecular Weight Heparin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 He'nan Xuchang Huaren Pharmaceutical Low Molecular Weight Heparin Injection Product Portfolio
  42. 8.7.5 He'nan Xuchang Huaren Pharmaceutical Recent Developments
  43. 8.8 Sanofi
  44. 8.8.1 Sanofi Company Information
  45. 8.8.2 Sanofi Business Overview
  46. 8.8.3 Sanofi Low Molecular Weight Heparin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sanofi Low Molecular Weight Heparin Injection Product Portfolio
  48. 8.8.5 Sanofi Recent Developments
  49. 8.9 Pfizer
  50. 8.9.1 Pfizer Company Information
  51. 8.9.2 Pfizer Business Overview
  52. 8.9.3 Pfizer Low Molecular Weight Heparin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Pfizer Low Molecular Weight Heparin Injection Product Portfolio
  54. 8.9.5 Pfizer Recent Developments
  55. 8.10 Opocrin
  56. 8.10.1 Opocrin Company Information
  57. 8.10.2 Opocrin Business Overview
  58. 8.10.3 Opocrin Low Molecular Weight Heparin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Opocrin Low Molecular Weight Heparin Injection Product Portfolio
  60. 8.10.5 Opocrin Recent Developments
  61. 8.11 Aspen
  62. 8.11.1 Aspen Company Information
  63. 8.11.2 Aspen Business Overview
  64. 8.11.3 Aspen Low Molecular Weight Heparin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Aspen Low Molecular Weight Heparin Injection Product Portfolio
  66. 8.11.5 Aspen Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Low Molecular Weight Heparin Injection Value Chain Analysis
  2. 9.1.1 Low Molecular Weight Heparin Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Low Molecular Weight Heparin Injection Production Mode & Process
  6. 9.2 Low Molecular Weight Heparin Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Low Molecular Weight Heparin Injection Distributors
  9. 9.2.3 Low Molecular Weight Heparin Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst